Approved comparison material connected to this topic.
4 total recordsSource comparisons are presented without a generated winner.
CJC-1295 is one of several peptides that stimulate growth hormone release, but its effects on sleep architecture differ meaningfully from alternatives like ipamorelin, GHRP-2, or MK 677 (ibutamoren). Understan…
| Protocol Variant | Dosage | Timing | Expected SWS Increase | Cortisol Impact | Best For | Professional Assessment ||—|—|—|—|—|—|| Standard Evening Protocol | 100–150mcg | 2 hours pre-bed | 12–18% | Minimal d…
CJC-1295 DAC GHRH receptor agonist. Amplifies endogenous GH pulses during SWS Slow-wave sleep (Stage N3) duration +15–25% 2–3 hours pre-sleep for circadian alignment GHRH receptor (anterior pituitary somatotro…
CJC-1295 (with DAC) GHRH receptor agonist Animal models show 18–23% SWS increase; human trials measure GH/IGF-1 only 6–9 days per injection None published. Mechanistic inference only MK-677 (Ibutamoren) Ghreli…